September 12, 2025BMJ Open Respiratory ResearchOpen Access

Differentiating clinically important interstitial lung abnormalities in lung cancer screening

View Full Paper

Ask AI

Bookmark

Authors

BSBrintha Selvarajah ABAmyn Bhamani MAMehran Azimbagirad

Discussion

Member takes

Implication

Analysis demonstrates a new classification for identifying interstitial lung abnormalities in lung cancer screening, highlighting their impact on mortality and comorbidities.

Key Points

A new classification system for interstitial lung abnormalities improves observer agreement, showing Kappa values of 0.76 compared to 0.64 for existing methods.
Mortality rates in patients with undiagnosed interstitial lung disease are six-fold higher than controls, emphasizing the serious implications of these abnormalities.
Analysis revealed that interstitial lung abnormalities were associated with more prevalent comorbidities about ten years prior to diagnosis compared to matched controls.
The presence of interstitial lung abnormalities showed a stronger independent association with mortality than baseline forced vital capacity measurements.

Cite This Study

Selvarajah et al. (2025) studied this question.

synapsesocial.com/papers/68d41d94713b0b5dfea663ee https://doi.org/10.1136/bmjresp-2025-003298

View Full Paper

Ask AI

Bookmark

Implication

Analysis demonstrates a new classification for identifying interstitial lung abnormalities in lung cancer screening, highlighting their impact on mortality and comorbidities.

Differentiating clinically important interstitial lung abnormalities in lung cancer screening

Discussion

Member takes

Implication

Key Points

Cite This Study

Differentiating clinically important interstitial lung abnormalities in lung cancer screening

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider